Results 91 to 100 of about 7,072 (218)

Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction.

PLoS ONE, 2019
BackgroundHeart failure with mid-range ejection fraction (HFmrEF) has been proposed as a new phenotype of heart failure. We therefore investigated the pulsatile hemodynamic characteristics and outcomes in patients with HFmrEF, in comparison with those ...
Wei-Ming Huang, Shih-Hsien Sung, Wen-Chung Yu, Hao-Min Cheng, Chi-Jung Huang, Chao-Yu Guo, Dai-Yin Lu, Ching-Wei Lee, Chen-Huan Chen   +8 more
doaj   +1 more source

Conduction System Pacing Versus Biventricular Cardiac Resynchronization in HFmrEF: A Systematic Review and Meta‐Analysis

Annals of Noninvasive Electrocardiology, Volume 31, Issue 3, May 2026.
CSP, particularly LBBP, appears superior to BiVP in reducing HFH and enhancing electrical resynchronization in HFmrEF. Large randomized trials are warranted to confirm these findings and establish CSP as a standard resynchronization strategy. ABSTRACT Objective To compare the efficacy and safety of conduction system pacing (CSP) versus biventricular ...
Mounika Kotte, Imad Sibhai, Zaid Shaikh, Mohammed Amreliya, Jahanzeb Malik, Aadil Memon, Bhavna Singla, Shivam Singla, Muhammad Subhan, FNU Sandesh, Pooja Kumari, Abida Perveen   +11 more
wiley   +1 more source

Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF [PDF]

, 2020
Background: Elderly heart failure (HF) patients are underrepresented in clinical trials, though are a large proportion of patients in real-world practice.
Brugts, J.J. (Jasper), Brunner La Rocca, H.P. (Hans Peter), Dalen, B.M. (Bas) van, de Valk-Bedijn, W. (Wendy), Grosfeld, M.J.W. (Marcel J. W.), Hoes, A.W. (Arno), Kleberger, A. (Alexandra), Langerveld, J. (Jorina), Linssen, G.C.M. (Gerard), Veenis, J.F. (Jesse), Viergever, E.P. (Eric)   +10 more
core   +3 more sources

Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3568-3581, May 2026.
Abstract The mineralocorticoid receptor (MR) has a multifaceted role in normal physiologic functions. However, research has uncovered the deleterious consequences of overactivation of the MR. It has been implicated in chronic kidney disease (CKD) via its strong association with glomerulosclerosis, interstitial fibrosis, proteinuria, and decline in ...
Amy K. Mottl, Kamlesh Khunti, Chantal Mathieu   +2 more
wiley   +1 more source

Echocardiographic and Clinical Correlates of Ejection Fraction Among 2000 Patients with Heart Failure in Western Saudi Arabia

International Journal of General Medicine, 2020
Ahmed Hussein Subki,1 Mohammed Ali Almalki,2 Nadeem Shafique Butt,3 Mohammed Saad Alsallum,4 Hatim Mashan Almutairi,5 Hazim Abdulkarim Khatib,6 Abdulrahman Mousa Alzahrani,6 Abdullah Salem Babaker,6 Firas Abdulrahman Addas,6 Abdullah Abdulfattah Mashat,7
Subki AH, Almalki MA, Butt NS, Alsallum MS, Almutairi HM, Khatib HA, Alzahrani AM, Babaker AS, Addas FA, Mashat AA, Jad AY, Zafar ZA, Nogali BW, Alghamdi AA, Alghamdi NA, Dakhakhni MF, Asaad OT, Alghalayini KW   +17 more
doaj  

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2018
Objective: To assess the effects of comorbidities, fragility, and quality of life (QOL) on long-term prognosis in ambulatory patients with heart failure (HF) with midrange left ventricular ejection fraction (HFmrEF), an unexplored area.
Paloma Gastelurrutia, PhD, Josep Lupón, MD, PhD, Pedro Moliner, MD, Xiaobo Yang, MB, German Cediel, MD, PhD, Marta de Antonio, MD, PhD, Mar Domingo, MD, PhD, Salvador Altimir, MD, Beatriz González, CN, Margarita Rodríguez, CN, Carmen Rivas, CN, Violeta Díaz, CN, Erik Fung, MB, ChB, PhD, Elisabet Zamora, MD, PhD, Javier Santesmases, MD, Julio Núñez, MD, PhD, Jean Woo, MD, Antoni Bayes-Genis, MD, PhD, FESC   +17 more
doaj   +1 more source

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect

Acta Biomedica Scientifica
Introduction. A new class of chronic heart failure (CHF) has been identified recently – heart failure with mildly reduced left ventricular ejection fraction (HFmrEF). The determinants and outcomes of this phenotype are still being clarified.The aim.
M. T. Duishenalieva, A. G. Polupanov, F. T. Rysmatova, E. Zh. Myrzabekova, N. E. Esenbekova, N. Ch. Cholponbekova, E. Sh. Altymyshova, A. T. Arykova, N. B. Cheskidova, E. D. Djyshambaev   +9 more
doaj   +1 more source

Association between serum matrix metalloproteinase-12/angiotensin II profile and left ventricular hypertrophy in patients with heart failure

Archives of the Balkan Medical Union, 2020
Introduction. Matrix metalloproteinases (MMPs) are important target genes for angiotensin II (AII), which subsequently alters MMP expression in extracellular matrix (ECM) and lead to remodeling process. Objective. To investigate whether an association
Asparuh G. NIKOLOV, Maria L. TZEKOVA, Konstantin M. KOSTOV, Alexander B. BLAZHEV   +3 more
doaj   +1 more source

Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction [PDF]

, 2020
Background: Continued high mortality in heart failure patients indicates the need for additional methods of risk stratification and phenotyping. Hypothesis: We hypothesized that ventricular arrhythmias that do not meet test-termination criteria (non ...
Arena R., Guazzi M., Jakovljevic D., Popovic D., Ristic A.   +4 more
core   +1 more source

Effect of Post‐Ablational Angiotensin Receptor‐Neprilysin Inhibitor on Atrial Fibrillation Recurrence: A Systematic Review and Meta‐Analysis in Asian Population

Clinical Cardiology, Volume 49, Issue 4, April 2026.
In this meta‐analysis of randomized controlled trials and cohort studies comparing angiotensin receptor‐neprilysin inhibitor (ARNI), angiotensin‐converting enzyme inhibitor and/or angiotensin receptor blocker (ACEI/ARB), and no‐treatment control, the use of ARNI may be effective in preventing the recurrence of atrial fibrillation (AF) after ablation ...
Yangyang Wang, Wenjing Zhang, Yang Shao, Qiming Dong, Yunfei Gu, Hao Wang   +5 more
wiley   +1 more source